GRANULES INDIA
Back to Balance Sheet
|
GRANULES INDIA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹3.04 Cr | ₹3.04 Cr | ₹3.04 Cr | ₹0.99 Cr | ₹0.99 Cr |
What is the latest Contingent Liabilities ratio of GRANULES INDIA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹3.04 Cr |
| Mar2024 | ₹3.04 Cr |
| Mar2023 | ₹3.04 Cr |
| Mar2022 | ₹0.99 Cr |
| Mar2021 | ₹0.99 Cr |
How is Contingent Liabilities of GRANULES INDIA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.04 Cr | 0.00 | |
| Mar2024 | ₹3.04 Cr | 0.00 | |
| Mar2023 | ₹3.04 Cr | 206.14 | |
| Mar2022 | ₹0.99 Cr | 0.00 | |
| Mar2021 | ₹0.99 Cr | - | |
Compare Contingent Liabilities of peers of GRANULES INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GRANULES INDIA | ₹13,689.5 Cr | -1.4% | -6.4% | -2.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,827.0 Cr | -0.4% | -0.1% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,363.0 Cr | 0.9% | -3% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,193.0 Cr | 2% | 1.7% | 25.2% | Stock Analytics | |
| CIPLA | ₹109,519.0 Cr | -0.9% | -7.2% | -9.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,940.0 Cr | -0.6% | 6.8% | 2.7% | Stock Analytics | |
GRANULES INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GRANULES INDIA | -1.4% |
-6.4% |
-2.3% |
| SENSEX | -0.9% |
-0.1% |
7% |
You may also like the below Video Courses